Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Landmark research toward increasing survival rates for aggressive childhood cancer
A new combination of drugs could help to increase survival rates with fewer side effects…
Global demand for cancer surgery set to grow by almost 5 million procedures within 20 years
Demand for cancer surgery is expected to increase from 9.1 million to 13.8 million procedures…
Singles or pairs in cancer cells
It all sounds similar to a dance event – but are singles or couples dancing…
Three charts on cancer rates in Australia: where liver cancer is on the rise while other types fall
Terry Slevin, Cancer Council Australia Liver cancer is a looming health threat in Australia, recent findings from the Australian Institute…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.